1. A randomized, placebo-controlled, single ascending-dose study to assess the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous tralokinumab in Japanese healthy volunteers. Issue 3 (June 2018) Authors: Baverel, Paul; She, Dewei; Piper, Edward; Ueda, Shinya; Yoshioka, Tomoko; Faggioni, Raffaella; Gevorkyan, Hakop Journal: Drug metabolism and pharmacokinetics Issue: Volume 33:Issue 3(2018) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exposure–Response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease Status. Issue 5 (12th April 2019) Authors: Baverel, Paul; Roskos, Lorin; Tatipalli, Manasa; Lee, Nancy; Stockman, Paul; Taboada, Maria; Vicini, Paolo; Horgan, Kevin; Narwal, Rajesh Journal: Clinical and translational science Issue: Volume 12:Issue 5(2019) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗